Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001078782-13-000264
Filing Date
2013-02-07
Accepted
2013-02-07 21:18:20
Documents
4
Effectiveness Date
2013-02-07

Document Format Files

Seq Description Document Type Size
1 S-1 REGISTRATION STATEMENT s1_s1mef.htm S-1MEF 39939
2 EXHIBIT 5.1 LEGAL OPINION AND CONSENT s1_ex5z1.htm EX-5.1 5081
3 EXHIBIT 23.1 AUDITOR'S CONSENT s1_ex23z1.htm EX-23.1 2258
4 IMAGE s1_ex5z1002.gif GRAPHIC 9525
  Complete submission text file 0001078782-13-000264.txt   61791
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-186508 | Film No.: 13584452
SIC: 2834 Pharmaceutical Preparations